PH25645A - New 1,4-dihydropyridine, pharmaceutical compostions containg them, method of usethereof - Google Patents

New 1,4-dihydropyridine, pharmaceutical compostions containg them, method of usethereof

Info

Publication number
PH25645A
PH25645A PH37337A PH37337A PH25645A PH 25645 A PH25645 A PH 25645A PH 37337 A PH37337 A PH 37337A PH 37337 A PH37337 A PH 37337A PH 25645 A PH25645 A PH 25645A
Authority
PH
Philippines
Prior art keywords
new
methyl
usethereof
containg
dihydropyridine
Prior art date
Application number
PH37337A
Other languages
English (en)
Inventor
Carlos Fernadez Torija
Joaquin Alvaro Galiano Ramos
Original Assignee
Inst Investigacion Desarrollo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Investigacion Desarrollo filed Critical Inst Investigacion Desarrollo
Publication of PH25645A publication Critical patent/PH25645A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PH37337A 1987-08-03 1988-08-03 New 1,4-dihydropyridine, pharmaceutical compostions containg them, method of usethereof PH25645A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401799A EP0302980B1 (fr) 1987-08-03 1987-08-03 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (1)

Publication Number Publication Date
PH25645A true PH25645A (en) 1991-08-21

Family

ID=8198243

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37337A PH25645A (en) 1987-08-03 1988-08-03 New 1,4-dihydropyridine, pharmaceutical compostions containg them, method of usethereof

Country Status (34)

Country Link
US (1) US4952592A (no)
EP (1) EP0302980B1 (no)
JP (1) JPH0733383B2 (no)
KR (1) KR960001724B1 (no)
CN (1) CN1038587C (no)
AT (1) ATE61588T1 (no)
BE (1) BE1001055A4 (no)
CA (2) CA1306261C (no)
CH (1) CH675999A5 (no)
CZ (1) CZ282077B6 (no)
DD (1) DD282008A5 (no)
DE (2) DE3768658D1 (no)
DK (1) DK430288A (no)
ES (1) ES2007543A6 (no)
FI (1) FI91406C (no)
GB (1) GB2208861B (no)
GR (2) GR880100507A (no)
HU (1) HU204523B (no)
IE (1) IE60358B1 (no)
IL (1) IL87321A (no)
IN (1) IN167550B (no)
IS (1) IS1549B (no)
IT (1) IT1235013B (no)
LU (1) LU87297A1 (no)
MA (1) MA21344A1 (no)
NO (1) NO170934C (no)
NZ (1) NZ225661A (no)
PH (1) PH25645A (no)
PT (1) PT88173B (no)
RU (1) RU2036922C1 (no)
SK (1) SK278775B6 (no)
TN (1) TNSN88081A1 (no)
YU (1) YU46547B (no)
ZA (1) ZA885684B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
DE69616364T2 (de) * 1995-08-02 2002-07-11 Smithkline Beecham Corp Endothelinrezeptorantagonisten
CZ301790B6 (cs) * 2000-04-11 2010-06-23 Sankyo Company Limited Farmaceutický prípravek obsahující blokátor vápníku
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
JP2008507585A (ja) * 2004-07-26 2008-03-13 コセリックス インク 微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
ES8507495A1 (es) * 1984-03-27 1985-09-01 Inst Investigacion Desarrollo Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
JPH068294B2 (ja) * 1985-02-26 1994-02-02 富山化学工業株式会社 新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤

Also Published As

Publication number Publication date
IE882364L (en) 1989-02-03
DD282008A5 (de) 1990-08-29
GR3001984T3 (en) 1992-11-23
EP0302980A1 (fr) 1989-02-15
GB2208861A (en) 1989-04-19
IS1549B (is) 1994-06-08
CN1031531A (zh) 1989-03-08
CH675999A5 (en) 1990-11-30
IE60358B1 (en) 1994-06-29
CA1306262C (fr) 1992-08-11
ZA885684B (en) 1989-04-26
RU2036922C1 (ru) 1995-06-09
BE1001055A4 (fr) 1989-06-20
HUT54142A (en) 1991-01-28
LU87297A1 (fr) 1989-02-02
EP0302980B1 (fr) 1991-03-13
GR880100507A (el) 1989-05-25
NO170934C (no) 1992-12-30
DE3768658D1 (de) 1991-04-18
CA1306261C (fr) 1992-08-11
US4952592A (en) 1990-08-28
IL87321A (en) 1993-04-04
HU204523B (en) 1992-01-28
SK541388A3 (en) 1998-02-04
GB8818356D0 (en) 1988-09-07
YU147088A (en) 1990-04-30
PT88173B (pt) 1995-03-01
CZ541388A3 (en) 1997-01-15
DK430288A (da) 1989-02-03
SK278775B6 (sk) 1998-02-04
IT8848259A0 (it) 1988-08-02
NZ225661A (en) 1990-08-28
IT1235013B (it) 1992-06-16
AU606441B2 (en) 1991-02-07
JPH01294675A (ja) 1989-11-28
ES2007543A6 (es) 1989-06-16
FI91406C (fi) 1994-06-27
JPH0733383B2 (ja) 1995-04-12
PT88173A (pt) 1989-06-30
GB2208861B (en) 1991-07-17
FI883603A (fi) 1989-02-04
CZ282077B6 (cs) 1997-05-14
YU46547B (sh) 1993-11-16
DE3825962A1 (de) 1989-02-16
AU2033088A (en) 1989-02-09
KR960001724B1 (ko) 1996-02-03
MA21344A1 (fr) 1989-04-01
NO883406D0 (no) 1988-08-01
NO883406L (no) 1989-02-06
IL87321A0 (en) 1989-01-31
ATE61588T1 (de) 1991-03-15
TNSN88081A1 (fr) 1990-07-10
IN167550B (no) 1990-11-10
CN1038587C (zh) 1998-06-03
DK430288D0 (da) 1988-08-02
FI883603A0 (fi) 1988-08-01
FI91406B (fi) 1994-03-15
NO170934B (no) 1992-09-21
KR890003743A (ko) 1989-04-17
IS3378A7 (is) 1989-02-04

Similar Documents

Publication Publication Date Title
PH25645A (en) New 1,4-dihydropyridine, pharmaceutical compostions containg them, method of usethereof
FI900307A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
SE9704870D0 (sv) New pharmaceutical formulation I
TW360656B (en) Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof
NL940010I2 (nl) Nieuwe 2beta-morfolino-androstaanderivaten en werkwijze voor de bereiding daarvan.
AU7508087A (en) New 4-pyridone derivatives, method of their production and their pharmaceutical compositions
MD1744F2 (ro) Săruri ale acidului clavulanic şi procedeu de obţinere a lor
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
IL87561A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IE813100L (en) Naphthyridine derivatives
SE8605255D0 (sv) 4h-benzo(4,5)cyclohepta(1,2-b)thiophene derivatives
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
HUT45255A (en) Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds
PT83883A (en) Process for the preparation of 4h-benzo]4,5"cyclohepta]1,2-b"thiophene derivatives
DE3474962D1 (en) 2-(2-thienyl)-imidazoû4,5-b¨pyridine derivatives, pharmaceutically compatible acid addition salts of them, and process for their preparation
HUP9902630A2 (hu) Heterociklusos gyűrűvel kondenzált tieno-piridin-származékok, eljárás előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
FI943730A0 (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi
IT9021210A0 (it) Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono